DrugPatentWatch Database Preview
Investigational Drug Information for Crenolanib
Email this page to a colleague
What is the drug development status for Crenolanib?
Crenolanib is an investigational drug.
There have been 17 clinical trials for Crenolanib.
The most recent clinical trial was a Phase 2 trial, which was initiated on June 5th 2018.
The most common disease conditions in clinical trials are Leukemia, Myeloid, Acute, Leukemia, Myeloid, and Leukemia. The leading clinical trial sponsors are Arog Pharmaceuticals, Inc., St. Jude Children's Research Hospital, and The V Foundation for Cancer Research.
There are one hundred and eighty-six US patents protecting this investigational drug and one international patent.
Summary for Crenolanib
| US Patents | 186 |
| International Patents | 1,365 |
| US Patent Applications | 591 |
| WIPO Patent Applications | 464 |
| Japanese Patent Applications | 55 |
| Clinical Trial Progress | Phase 2 (2018-06-05) |
| Vendors | 65 |
Recent Clinical Trials for Crenolanib
| Title | Sponsor | Phase |
|---|---|---|
| Study of Crenolanib vs Midostaurin Following Induction Chemotherapy and Consolidation Therapy in Newly Diagnosed FLT3 Mutated AML | Arog Pharmaceuticals, Inc. | Phase 3 |
| Study Investigating the Efficacy of Crenolanib With Chemotherapy vs Chemotherapy Alone in R/R FLT3 Mutated AML | Arog Pharmaceuticals, Inc. | Phase 3 |
| A Study of Crenolanib With Fludarabine and Cytarabine in Pediatric Patients With Relapsed/Refractory FLT3-Mutated Acute Myeloid Leukemia | Arog Pharmaceuticals, Inc. | Phase 2 |
Clinical Trial Summary for Crenolanib
Top disease conditions for Crenolanib
Top clinical trial sponsors for Crenolanib
US Patents for Crenolanib
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Crenolanib | ⤷ Try it Free | Peptides and combination of peptides for use in immunotherapy against various tumors | IMMATICS BIOTECHNOLOGY GMBH (Tuebingen, DE) | ⤷ Try it Free |
| Crenolanib | ⤷ Try it Free | Therapeutic uses of selected pyrrolopyrimidine compounds with anti-mer tyrosine kinase activity | The University of North Carolina at Chapel Hill (Chapel Hill, NC) | ⤷ Try it Free |
| Crenolanib | ⤷ Try it Free | Peptides and combination of peptides for use in immunotherapy against various tumors | IMMATICS BIOTECHNOLOGIES GMBH (Tuebingen, DE) | ⤷ Try it Free |
| Crenolanib | ⤷ Try it Free | Human anti-VEGFR-2/KDR antibodies | KADMON CORPORATION, LLC (New York, NY) | ⤷ Try it Free |
| Crenolanib | ⤷ Try it Free | Treatment of myelodysplastic syndromes with 2-O and,or 3-O desulfated heparinoids | Cantex Pharmaceuticals, Inc. (Weston, FL) | ⤷ Try it Free |
| Crenolanib | ⤷ Try it Free | Substituted heteroaryl compounds and methods of use | CALITOR SCIENCES, LLC (Newbury Park, CA) SUNSHINE LAKE PHARMA CO., LTD. (Dongguan, Guangdong, CN) | ⤷ Try it Free |
| Crenolanib | ⤷ Try it Free | Peptides and combination of peptides for use in immunotherapy against various tumors | IMMATICS BIOTECHNOLOGIES GMBH (Tuebingen, DE) | ⤷ Try it Free |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Crenolanib
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Crenolanib | Argentina | AR104113 | 2035-03-27 | ⤷ Try it Free |
| Crenolanib | Argentina | AR112781 | 2035-03-27 | ⤷ Try it Free |
| Crenolanib | Australia | AU2016239920 | 2035-03-27 | ⤷ Try it Free |
| Crenolanib | Australia | AU2018232952 | 2035-03-27 | ⤷ Try it Free |
| Crenolanib | Australia | AU2019202561 | 2035-03-27 | ⤷ Try it Free |
| Crenolanib | Australia | AU2019222976 | 2035-03-27 | ⤷ Try it Free |
| Crenolanib | Australia | AU2020256298 | 2035-03-27 | ⤷ Try it Free |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
